Redefining hyperviscosity in acute leukemia: Potential implications for red cell transfusions in the microvasculature
American Journal of Hematology · 2024
DOI: 10.1002/ajh.27308 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hematology, 2024. Verfasst von Jamie O Musick und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, …. Hauptthemen laut MEDLINE: Blood Viscosity, Erythrocyte Transfusion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: National Institutes of Health, National Heart, Lung, and Blood Institute, National Institutes of Health.
Abstract (Originalsprache)
Hyperleukocytosis is an emergency of acute leukemia leading to blood hyperviscosity, potentially resulting in life‐threatening microvascular obstruction, or leukostasis. Due to the high number of red cells in the circulation, hematocrit/hemoglobin levels (Hct/Hgb) are major drivers of blood viscosity, but how Hct/Hgb mediates hyperviscosity in acute leukemia remains unknown. In vivo hemorheological studies are difficult to conduct and interpret due to issues related to visualizing and manipulating the microvasculature. To that end, a multi‐vessel microfluidic device recapitulating the size‐scale and geometry of the microvasculature was designed to investigate how Hct/Hgb interacts with acute leukemia to induce “in vitro” leukostasis. Using patient samples and cell lines, the degree of leukostasis was different among leukemia immunophenotypes with respect to white blood cell (WBC) count and Hct/Hgb. Among lymphoid immunophenotypes, severe anemia is protective against in vitro leukostasis and Hct/Hgb thresholds became apparent above which in vitro leukostasis significantly increased, to a greater extent with B‐cell acute lymphoblastic leukemia (ALL) versus T‐cell ALL. In vitro leukostasis in acute myeloid leukemia was primarily driven by WBC with little interaction with Hct/Hgb. This sets the stage for prospective clinical studies assessing how red cell transfusion may affect leukostasis risk in immunophenotypically different acute leukemia patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia, USA.
- Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, Georgia, USA.
- George W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA.
ORCID-Profile: Evelyn K Williams, Dan Y Zhang
Förderung
- National Institutes of Health, National Heart, Lung, and Blood Institute
- National Institutes of Health
Zitieren
APA
Musick, J. O., Williams, E. K., Fibben, K. S., Zhang, D. Y., Caruso, C., Sakurai, Y., Tran, R., Kemp, M. L., & Lam, W. A. (2024). Redefining hyperviscosity in acute leukemia: Potential implications for red cell transfusions in the microvasculature. American Journal of Hematology. https://doi.org/10.1002/ajh.27308
Vancouver
Musick JO, Williams EK, Fibben KS, Zhang DY, Caruso C, Sakurai Y, et al. Redefining hyperviscosity in acute leukemia: Potential implications for red cell transfusions in the microvasculature. American Journal of Hematology. 2024. doi:10.1002/ajh.27308
BibTeX
@article{Musick2024,
author = {Musick, Jamie O and Williams, Evelyn K and Fibben, Kirby S and Zhang, Dan Y and Caruso, Christina and Sakurai, Yumiko and Tran, Reginald and Kemp, Melissa L and Lam, Wilbur A},
title = {Redefining hyperviscosity in acute leukemia: Potential implications for red cell transfusions in the microvasculature},
journal = {American Journal of Hematology},
year = {2024},
doi = {10.1002/ajh.27308}
}
EUVIMED